Morepen Laboratories Limited

NSEI:MOREPENLAB 株式レポート

時価総額:₹42.7b

Morepen Laboratories マネジメント

マネジメント 基準チェック /34

Morepen Laboratoriesの CEO はSushil Suriで、 Oct2000年に任命され、 の在任期間は 24.08年です。 は、会社の株式の1.22%を直接所有しており、その価値は₹ 522.17M 。経営陣と取締役会の平均在任期間はそれぞれ7.9年と4.8年です。

主要情報

Sushil Suri

最高経営責任者

₹39.1m

報酬総額

CEO給与比率n/a
CEO在任期間24.1yrs
CEOの所有権1.2%
経営陣の平均在職期間7.9yrs
取締役会の平均在任期間4.8yrs

経営陣の近況

Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Sep 22
Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Recent updates

There's Reason For Concern Over Morepen Laboratories Limited's (NSE:MOREPENLAB) Massive 30% Price Jump

Aug 20
There's Reason For Concern Over Morepen Laboratories Limited's (NSE:MOREPENLAB) Massive 30% Price Jump

Impressive Earnings May Not Tell The Whole Story For Morepen Laboratories (NSE:MOREPENLAB)

Aug 09
Impressive Earnings May Not Tell The Whole Story For Morepen Laboratories (NSE:MOREPENLAB)

Improved Earnings Required Before Morepen Laboratories Limited (NSE:MOREPENLAB) Stock's 29% Jump Looks Justified

Jul 05
Improved Earnings Required Before Morepen Laboratories Limited (NSE:MOREPENLAB) Stock's 29% Jump Looks Justified

Does Morepen Laboratories (NSE:MOREPENLAB) Have A Healthy Balance Sheet?

Jun 13
Does Morepen Laboratories (NSE:MOREPENLAB) Have A Healthy Balance Sheet?

Morepen Laboratories Limited's (NSE:MOREPENLAB) Popularity With Investors Is Under Threat From Overpricing

Apr 23
Morepen Laboratories Limited's (NSE:MOREPENLAB) Popularity With Investors Is Under Threat From Overpricing

Morepen Laboratories (NSE:MOREPENLAB) Seems To Use Debt Quite Sensibly

Nov 23
Morepen Laboratories (NSE:MOREPENLAB) Seems To Use Debt Quite Sensibly

Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Sep 22
Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?

Aug 10
Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?

Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Sep 21
Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)

Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?

Apr 05
Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?

Do Morepen Laboratories's (NSE:MOREPENLAB) Earnings Warrant Your Attention?

Sep 14
Do Morepen Laboratories's (NSE:MOREPENLAB) Earnings Warrant Your Attention?

Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?

May 21
Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?

Does Morepen Laboratories (NSE:MOREPENLAB) Deserve A Spot On Your Watchlist?

Mar 12
Does Morepen Laboratories (NSE:MOREPENLAB) Deserve A Spot On Your Watchlist?

Our View On Morepen Laboratories' (NSE:MOREPENLAB) CEO Pay

Feb 22
Our View On Morepen Laboratories' (NSE:MOREPENLAB) CEO Pay

Is Morepen Laboratories Limited's (NSE:MOREPENLAB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Feb 07
Is Morepen Laboratories Limited's (NSE:MOREPENLAB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Morepen Laboratories (NSE:MOREPENLAB) Shareholders Have Enjoyed A 91% Share Price Gain

Jan 21
Morepen Laboratories (NSE:MOREPENLAB) Shareholders Have Enjoyed A 91% Share Price Gain

Morepen Laboratories (NSE:MOREPENLAB) Has A Pretty Healthy Balance Sheet

Jan 03
Morepen Laboratories (NSE:MOREPENLAB) Has A Pretty Healthy Balance Sheet

Is There More To The Story Than Morepen Laboratories's (NSE:MOREPENLAB) Earnings Growth?

Dec 16
Is There More To The Story Than Morepen Laboratories's (NSE:MOREPENLAB) Earnings Growth?

Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?

Nov 28
Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?

CEO報酬分析

Morepen Laboratories の収益と比較して、Sushil Suri の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

₹1b

Jun 30 2024n/an/a

₹1b

Mar 31 2024₹39mn/a

₹962m

Dec 31 2023n/an/a

₹761m

Sep 30 2023n/an/a

₹531m

Jun 30 2023n/an/a

₹477m

Mar 31 2023₹48m₹44m

₹387m

Dec 31 2022n/an/a

₹428m

Sep 30 2022n/an/a

₹553m

Jun 30 2022n/an/a

₹768m

Mar 31 2022₹91m₹87m

₹1b

Dec 31 2021n/an/a

₹1b

Sep 30 2021n/an/a

₹1b

Jun 30 2021n/an/a

₹1b

Mar 31 2021₹54m₹51m

₹971m

Dec 31 2020n/an/a

₹814m

Sep 30 2020n/an/a

₹684m

Jun 30 2020n/an/a

₹453m

Mar 31 2020₹17m₹16m

₹336m

Dec 31 2019n/an/a

₹331m

Sep 30 2019n/an/a

₹312m

Jun 30 2019n/an/a

₹340m

Mar 31 2019₹12m₹11m

₹288m

Dec 31 2018n/an/a

₹252m

Sep 30 2018n/an/a

₹267m

Jun 30 2018n/an/a

₹308m

Mar 31 2018₹6m₹4m

₹296m

報酬と市場: Sushilの 総報酬 ($USD 463.09K ) は、 Indian市場 ($USD 266.16K ) の同規模の企業の平均を上回っています。

報酬と収益: Sushilの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Sushil Suri (60 yo)

24.1yrs

在職期間

₹39,112,000

報酬

Mr. Sushil Suri, B.Sc., FCA has been Managing Director of Morepen Laboratories Limited since October 2000. He has been Chairman of Morepen Laboratories Limited since October 2000 and has been its Director...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Sushil Suri
Chairman & MD24.1yrs₹39.11m1.22%
₹ 522.2m
Sanjay Suri
Whole-Time Director9.8yrs₹21.80m1.01%
₹ 429.8m
Ajay Sharma
Chief Financial Officer10.3yrs₹9.80mデータなし
Bhola Prasad
General Manager of Process Engineering & Technology Transferno dataデータなしデータなし
Sunita Suri
Manager of Administrationno dataデータなし0.58%
₹ 248.7m
Vipul Srivastava
Company Secretary & Compliance Officer6yrs₹1.84mデータなし
Vikas Sharma
Functional Head of Talent Acquisition & HRBPless than a yearデータなしデータなし
Amita Sharma
Chief Operating Officer of APIless than a yearデータなしデータなし
Anubhav Suri
Head of Medipath Divisionno dataデータなし0.42%
₹ 177.8m
Kushal Suri
Head of International Business Developmentno dataデータなしデータなし
Varun Suri
Chief Executive Officer of Consumer Divisionno dataデータなし0.56%
₹ 237.8m
H. Manjunath
Chief of R&Dno dataデータなしデータなし

7.9yrs

平均在職期間

47.5yo

平均年齢

経験豊富な経営陣: MOREPENLABの経営陣は経験豊富で経験豊富です(平均在職期間は7.9年)。


取締役

名称ポジション在職期間報酬所有権
Sushil Suri
Chairman & MD32.8yrs₹39.11m1.22%
₹ 522.2m
Sanjay Suri
Whole-Time Director5.3yrs₹21.80m1.01%
₹ 429.8m
Sharad Jain
Independent Directorless than a yearデータなしデータなし
Praveen Dutt
Independent Director5.3yrs₹520.00kデータなし
- Savita
Independent Director4.4yrs₹300.00kデータなし
Ranjit Khattar
Independent Directorless than a yearデータなしデータなし

4.8yrs

平均在職期間

56yo

平均年齢

経験豊富なボード: MOREPENLABの 取締役会経験豊富 であると考えられます ( 4.8年の平均在任期間)。